It has been suggested that maspin dysregulation in tumours may be because of altered expressions of various transregulators acting on the maspin promoter, including the proteins Ets and Ap1 (Zhang et al, 1997) and p53 (Zou et al, 2000). The gene discussed is SERPINB5; the disease is neoplasm.